Eric L. Sorkin Chairman and Chief Executive Officer
Mr. Sorkin has 25 years of making strategic investments and business development. He has been
affiliated with Immtech since 1998, when he became an investor. In 2000, Mr. Sorkin became a director
for the Company, and more recently was appointed Chairman of the Board and CEO. Mr. Sorkin began
his career on Wall Street in 1982 working at Dean Witter, which is now a subsidiary of Morgan Stanley,
and from an entry-level position, he was promoted to Managing Director within six years. He was among
the core group of professionals at the firm, which developed the firm's investment portfolio with assets
of over USD $3 billion. Mr. Sorkin was responsible for investment selection, negotiations, transaction and
financial structuring, debt placement, and asset management. Mr. Sorkin was Officer of over 20 public
investment partnerships with investment funds totaling over USD $1 billion. In 1993, Mr. Sorkin created
his own investment firm and began making private equity investments in the U.S. and in China. Mr. Sorkin
graduated from Yale University with a B.A. in Economics.
Ms. Chan has 22 years of experience in making strategic investments and business development.
She began working on Immtech's growth strategy in 1998 and spearheaded Immtech's initial public
offering in April 1999. Ms. Chan is responsible for strategic development, creating joint ventures,
fundraising, and directing the Company's uses of capital resources as the firm advances through
its various growth stages and achievements. Prior to joining Immtech, Ms. Chan was a Vice President
at Dean Witter until 1993. During her eight years at that firm Ms. Chan completed over $500 million
in investments and was Officer of public partnerships with assets of over $800 million. Since 1993,
Ms. Chan has developed and funded investments in the U.S. and in China. She graduated from
New York University with a Bachelor of Science degree in International Business.
Gary C. Parks Secretary, Treasurer and Chief Financial Officer
Mr. Parks joined Immtech in January 1994, having previously served at Smallbone, Inc. from 1989 until 1993 where he was Vice President, Finance. Mr. Parks was a Division Controller with International Paper from 1986 to 1989. Prior to that, he was Vice President of SerckBaker, Inc., a subsidiary of BTR plc, from 1982 to 1989 and a board member of SerckBaker de Venezuela. Mr. Parks holds a B.A. from Principia College and an M.B.A. from the University of Michigan.
Norman A. Abood, PhD Senior Vice President, Discovery Programs
As Immtech's Senior Vice President of Discovery Programs, Dr. Abood works directly with the scientific consortium and contract vendors to develop and implement plans for each research program including, but not limited to, the antibacterial, antifungal, and antiviral programs. He has over 15 years experience in the healthcare and pharmaceutical industry. A former registered pharmacist, Dr. Abood received his B.S. Pharmacy and M.S. Medicinal Chemistry degrees from Massachusetts College of Pharmacy and Allied Health Sciences graduating in 1984. He completed his Ph.D. in Medicinal Chemistry from Ohio State University in 1987 and was awarded a Research Fellowship from the National Cancer Institute in 1986-1987. After completing a Postdoctoral Fellowship in Organic Chemistry at Indiana University, Dr. Abood held a number of supervisory roles as a Research Scientist in the Discovery Medicinal Chemistry Department at Searle between 1989 and 1999, and served as Senior Project Manager for Pharmacia/Pfizer R&D for the following five years, where he was responsible for advancing several early and late stage development projects through key milestones in the drug development process.
